Disparities in Activity Level and Nutrition Between Patients With Chronic Hepatitis C and Blood Donors

PM and R

Volumn 4, Issue 6, 2012, Pages 436-441

  Moon, Juhi ^a   Kallman, Jillian ^a   Winter, Patrice ^b   Srishord, Manirath ^a   Fang, Yun ^a   Gerber, Lynn ^b   Younossi, Zobair ^a  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD DONOR; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET; EXERCISE; FEMALE; HEPATITIS C; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE;

ADULT; AGED; BLOOD DONORS; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; NUTRITIONAL STATUS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 84862771837     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2012.02.020     Document Type: Article

References (49)

1. Hepatitis C World Health Organization, Accessed June 9, 2011. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index4.html.
2. Thomas D.L., Seeff L.B. Natural history of hepatitis C. Clin Liver Dis 2005, 9:383-398.
3. Hickman J., Jonsson J.R., Prins J.B., et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004, 53:413-419.
4. Rouillard S., Lane N. Hepatic osteodystrophy. Hepatology 2003, 33:301-307.
5. Sam J., Nguyen G. Protein calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int 2009, 29:1396-1402.
6. Cabre E., Gassull M.A. Nutrition in chronic liver disease and liver transplantation. Curr Opin Clin Nutr Metab Care 1998, 1:423-430.
7. Kalaitzakis E., Simren M., Olsson R., et al. Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life. Scand J Gastroenterol 2006, 41:1464-1472.
8. Gunsar F., Raimondo M.L., Jones S., et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006, 24:5635-5672.
9. Tsiaousi E.T., Hatzitolios A.I., Trygonis S.K., Savopoulos C.G. Malnutrition in end stage liver disease: Recommendations and nutritional support. J Gastroenterol Hepatol 2008, 23:527-533.
10. O'Brien A., Williams R. Nutrition in end-stage liver disease: Principles and practice. Gastroenterol 2008, 134:1729-1740.
11. Matos C., Porayko M.K., Francisco-Ziller N., DiCecco S. Nutrition and chronic liver disease. J Clin Gastroenterol 2002, 35:391-397.
12. Loguercio C., Federico A., Masarone M., Torella R., Del Vecchio Blanco C., Persico M. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis. Am J Gastroenterol 2008, 103:3159-3166.
13. Hickman I.J., Clouston A.D., Macdonald G.A., et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002, 51:89-94.
14. Dietary guidelines for Americans. Guidelines, 2005 U.S. Department of Health and Human Services, U.S. Department of Agriculture, Accessed June 9, 2011. http://www.health.gov/dietaryguidelines/.
15. Hourigan L.F. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999, 29:1215-1219.
16. Lonardo A., Loria P., Adinolfi L.E., Carulli N., Ruggiero G. Hepatitis C and steatosis: A reappraisal. J Viral Hepat 2006, 13:73-80.
17. Ioannou G.N., Morrow O.B., Connole M.L., Lee S.P. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 2009, 50:175-184.
18. Adams L.A., Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006, 82:315-322.
19. Huang M.A., Greenson J.K., Chao C., et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: A pilot study. Am J Gastroenterol 2005, 100:1072-1081.
20. Kim C.H., Kallman J., Bai C.H., et al. Nutritional assessments of patients with non-alcoholic fatty liver disease. Obes Surg 2010, 20:154-160.
21. Ainsworth B.E., Haskell W.L., Leon A.S., et al. Compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sports Exerc 1993, 25:71-80.
22. Ainsworth B.E., Haskell W.L., Whitt M.C., et al. Compendium of physical activities: An update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32(9 Suppl):S498-S504.
23. Fix A.J., Daughton D.M. Human Activity Profile 1988, Psychological Assessment Resources, Odessa, FL.
24. Haskell W.L., Lee I.M., Pate R.R., et al. Physical activity and public health updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007, 39:1423-1434.
25. Davidson M., de Morton N. A systematic review of the Human Activity Profile. Clin Rehabil 2007, 21:151-162.
26. Hetzler R.K., Stickley C.D., Shikuma C.M., et al. Validation of the human activity profile in HIV-positive individuals on HAART. HIV Clin Trials 2009, 10:254-260.
27. Simone N.L., Soule B.P., Gerber L., et al. Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: A pilot study. Radiat Oncol 2007, 2:19.
28. Overend T., Anderson C., Sawant A., Perryman B., Locking-Cusolito H. Relative and absolute reliability of physical function measures in people with end-stage renal disease. Physiother Can 2010, 62:122-128.
29. Bennell K.L., Hinman R.S., Crossley K.M., et al. Is the Human Activity Profile a useful measure in people with knee osteoarthritis?. J Rehabil Res Dev 2004, 41:621-630.
30. Bilek L.D., Venema D.M., Willett G.M., Lyden E.R. Use of the Human Activity Profile for estimating fitness in persons with arthritis. Arthritis Rheum 2008, 59:659-664.
31. Gerber L.H., Furst G., Yarboro C., et al. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis. Clin Exp Rheumatol 2003, 21:S65-S70.
32. Baas L.S. Self-care resources and activity as predictors of quality of life in persons after myocardial infarction. Dimens Crit Care Nurs 2004, 23:131-138.
33. Yates B.C., Price-Fowlkes T., Agrawal S. Barriers and facilitators of self-reported physical activity in cardiac patients. Res Nurs Health 2003, 26:459-469.
34. Daughton D.M., Fix A.J., Kass I., Bell C.W., Patil K.D. Maximum oxygen consumption and the ADAPT quality-of-life scale. Arch Phys Med Rehabil 1982, 63:620-622.
35. Craig J., Young C., Ennis M., Baker G., Boggild M. A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry 2003, 74:1225-1230.
36. Farrell M.J., Gibson S.J., Helme R.D. Measuring the activity of older people with chronic pain. Clin J Pain 1996, 12:612.
37. Packer T.L., Sauriol A., Brouwer B. Fatigue secondary to chronic illness: Postpolio syndrome, chronic fatigue syndrome and multiple sclerosis. Arch Phys Med Rehabil 1994, 75:1122-1126.
38. Sports Nutrition: A Practice Manual for Professionals 2006, American Dietetic Association, Chicago, IL. 4th ed. M. Dunford (Ed.).
39. Drewnowski A., Maillot M., Darmon N. Testing nutrient profile models in relation to energy density and energy cost. Eur J Clin Nutr 2009, 63:674-683.
40. Poynard T., Cacoub P., Ratziu V., et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002, 9:295-303.
41. Hassoun Z., Willems B., Deslauriers J., Nguyen B.N., Huet P.M. Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale. Dig Dis Sci 2002, 47:2674-2681.
42. Scognamiglio P., Galati V., Navarra A., et al. Impact of hepatitis C virus infection on lifestyle. World J Gastroenterol 2007, 13:2722-2726.
43. Yu M.C., Yuan J.M., Lu S.C. Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol 2008, 23(Suppl 1):S92-S97.
44. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349:825-832.
45. Hezode C., Lonjon I., Roudot-Thoraval F., Pawlotsky J.M., Zafrani E.S., Dhumeaux D. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: A prospective study. Aliment Pharmacol Ther 2003, 17:1031-1037.
46. Ritland S., Petlund C.F., Knudsen T., Skrede S. Improvement of physical capacity after long-term training in patients with chronic active hepatitis. Scand J Gastroenterol 1983, 18:1083-1087.
47. Jacobs K.A., Sherman W.M. The efficacy of carbohydrate supplementation and chronic high carbohydrate diets for improving endurance performance. Int J Sport Nutr 1999, 9:92-115.
48. Burke E.R. Better Nutrition's guide to fitness and sports supplementation. Better Nutrition Accessed June 9, 2011. http://findarticles.com/p/articles/mi_m0FKA/is_11_63/ai_83076752/.
49. Lonardo A., Adinolfi L.E., Loria P., Carulli N., Ruggiero G., Day C.P. Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease. Gastroenterol 2004, 126:586-597.